Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis
Clinical trial NCT00147329 · COMPLETED
Trial details
- NCT number
- NCT00147329
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.